Virtual IPTA 2022

11:00 - 12:00

Networking: Zoom Virtual Hangouts

Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations.

Session Details / Access

12:00 - 13:05

Opening Ceremony, Presidential Address and SOTA on Pandemic and Transplantation

Mignon I McCulloch, South Africa
Welcome to the Virtual IPTA 2022 Congress

Carlos O. Esquivel, United States
Welcome from the IPTA President

Dmytro D. Ivanov, Ukraine
The current situation of transplanted children in Ukraine

Tomas Seeman, Czech Republic
Welcome from Prague Organizing Chair and Concert by local transplant patients

Mignon I McCulloch, South Africa
Presidential Adress from IPTA Past President

Emily A. Blumberg, United States
Pandemic and Transplantation: Lessons learned from COVID-19

Session Details / Access

13:15 - 14:25

Oral Abstracts Session: Liver Clinical - Part 1

Su young Hong, Korea
Renal Replacement Therapy Is An Alarm Sign of Survival Outcome in Pediatric Liver Transplantation

Eui Soo Han, Korea
Long-term outcomes of left lateral segment grafts in low-weight pediatric recipients liver transplantation: comparing reduced versus full grafts

Florian Brinkert, Germany
Clinical outcome after combined liver and kidney transplantation in children in europe – a CERTAIN registry analysis

Katherine Harmann, United States
Immunizing pediatric liver transplant recipients against varicella virus using live-attenuated vaccination

Proshad Efune, United States
Intraoperative fluid administration during pediatric liver transplant surgery and postoperative outcomes: a retrospective multi-center analysis

Christine Hwang, United States
Pediatric Donation after Cardiac Death (DCD) Livers transplanted in adult recipients – appropriate utilization or missed opportunity for waitlisted children?

Session Details / Access

13:15 - 14:25

Oral Abstracts Session: Infectious Disease and Malignancies

Olivia M Martinez, United States
Mutations in Latent Membrane Protein 1 of Epstein Barr Virus are Associated with Increased Risk of Post-transplant Lymphoproliferative Disorder

Masaki Yamada, Japan
Early detection of Epstein Barr virus and cytomegalovirus seronegative donors are the risk factors of chronic high Epstein-Barr viral load carriage after pediatric living-donor-dominated liver transplantation program.

Joao Seda Neto, Brazil
Unresectable hepatoblastoma and pre-transplant factors associated with event-free survival

Jorge Arroyo Orvañanos, Mexico
Cytomegalovirus Infection and Disease in Pediatric Liver Transplantation: Burden of Disease Under a Preemptive Therapy Approach

Helena Genberg, Sweden
Single-dose rituximab induction may prevent EBV viremia in paediatric kidney recipients long-term: an investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)

Olga Charnaya, United States
Risk of Post-Transplant Malignancy in Pediatric Kidney Transplant Recipients is not Influenced by Induction Immunosuppression

Session Details / Access

13:15 - 14:25

Oral Abstracts Session: Immunosuppression

Roberto Tambucci, Belgium
Is ABO incompatible living donor liver transplantation really a good alternative for pediatric recipients?

Alisha Mavis, United States
Do Surveillance Liver Biopsies Alter the Immunosuppression Regimen in Pediatric Liver Transplant Recipients?

Thurid Ahlenstiel-Grunow, Germany
Steering of immunosuppression by virus-specific T cells after pediatric kidney transplantation in the randomized controlled IVIST trial

Paul Grimm, United States
Sequential hematopoietic stem cell transplantation (HSCT) followed by kidney transplant- 3 children who received αβT-cell/CD19 B-cell depleted HSCT followed by kidney transplant from same parental donor are rejection free and immunosuppression free with donor specific tolerance > 1year post kidney transplant

Mary M Chandran, United States
Impact of once-daily extended-release tacrolimus intrapatient variability in stable adolescent and young adult renal transplant recipients – 3 year results

Ashlene McKay, Canada
LDL apheresis for FSGS recurrence in pediatric kidney transplant recipients: A case series

Session Details / Access

14:30 - 15:40

Workshop: IPTA-SPLIT Session on Addressing the gap between pediatric organ demand and supply: New strategies to increase the graft pool

Mureo Kasahara, Japan
Use of non-conventional organs Monosegmental liver Living donation: A necessary technical evolution to care for the very small?

Blayne Amir Sayed, Canada
Living donation: Living donation for acute liver failure- is this possible and ethically acceptable?

Gordon Thomas, Australia
High risk organs and Livers from DCDs: When should these be considered in pediatrics?

Session Supported by

Session Details / Access

14:30 - 15:40

Workshop: IPTA-IPNA workshop on Equity, access and outcomes of pediatric kidney transplant recipients in 2022

Ruth McDonald, United States
PTLD prediction based on Epstein-Barr viral loads

Hui Kim Yap, Singapore
Improving access to transplantation internationally

Paul Grimm, United States
Making the right decision in accepting deceased donor organ offers at 3am

Session Supported by

Session Details / Access

14:30 - 15:40

Workshop: IPTA-IRTA workshop on Optimizing Intestinal Transplant Options

Taizo Hibi, Japan
The future options to expand the donor pool (living donor, dcd, perfusion)

Yaron Avitzur, Canada
Intestinal rehabilitation and intestinal failure: When to transplant

Jennifer Garcia, United States
Intestinal Transplant Puzzle: Picking the right pieces

Session Supported by

Session Details / Access

15:45 - 16:15

State-of-the-Art Session: CRISPR and Transplantation

Valeria R. Mas, United States
CRISPR and Transplantation

Session Details / Access

16:20 - 17:20

Industry Symposium: Integrating Donor-Derived Cell-Free DNA in Your Transplant Monitoring Toolkit

Hossein Tabriziani, United States

Sara Jandeska, United States

Natera Industry Symposium

Session Details / Access

17:20 - 17:25

Live Virtual Stretching Break

Break Supported by

Session Details / Access

17:25 - 17:55

Networking: Prague Trivia & Toast

Mignon I McCulloch, South Africa
IPTA 2022 Virtual Toast

Tomas Seeman, Czech Republic
Prague Trivia Game

Session Details / Access

18:00 - 19:10

Oral Abstracts Session: Kidney Clinical - Part 1

Felicia Kjaernet, Sweden
Long-term outcome and complications in paediatric ABO-incompatible living donor kidney transplantation with rituximab induction: A multi-centre investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG)

Dechu Puliyanda, United States
Long term tolerability and clinical outcomes associated with Tocilizumab (TCZ) therapy in the treatment of refractory antibody mediated rejection (ABMR) in 25 pediatric renal transplant recipients

Asha Moudgil, United States
Prevalence of Mycophenolate Mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: a PNRC study

Hyunwoong Chae, Canada
Adrenal insufficiency in pediatric kidney transplant recipients

Charlotte E Withers, United Kingdom
National study on the risks of COVID-19 for paediatric renal transplant recipients

Femke HM Vrieling-Prince, Netherlands
Renal graft loss during adolescence: is there a relationship between pubertal stage and activity of the immune system?

Session Details / Access

18:00 - 19:10

Oral Abstracts Session: Allied Health

Saba Masood, United States
A qualitative examination of posttraumatic stress symptoms in pediatric solid organ transplant patients: What is the traumatic stressor and how do the symptoms manifest?

Elizabeth S Christofferson, United States
Disparities and Barriers Associated with Pediatric Transplant Evaluation: A Comprehensive Analysis of the Impact on Time to Listing

Catherine Patterson, Canada
Allied health and nursing practices in pediatric solid organ transplantation: An international survey

Robin Deliva, Canada
Functional performance in pediatric heart transplant candidates and recipients: a retrospective review

Nikol K. Grishin, Canada
VEXT-A Virtual Exercise Training Program for Solid Organ Transplant Recipients

Jo Wray, United Kingdom
Quality of life of paediatric cardiothoracic transplant patients: parent-child agreement and association with family impact

Session Details / Access

18:00 - 19:10

Oral Abstracts Session: Miscellaneous

Esra Baskin, Turkey
Long Term Effects of Eplerenone Treatment in Children with Chronic Allograft Dysfunction

Gabor A. Dunay, Germany
The role of tissue resident memory T cells in pediatric liver transplantation

Huib de Jong, Netherlands
Neutrophil gelatinase-associated lipocalin (NGAL) and Interleukine-18 (IL-18) in graft urine correlate with the rate of recovery of transplanted kidneys in children

Arpit Amin, United States
Kidney transplant in pediatric gut transplant recipients – Technical Challenges and Outcomes

Raphael Schild, Germany
Outcome after pediatric kidney transplantation from very small donors: a match-controlled CERTAIN Registry study.

Christine Hwang, United States
Delayed Graft Function In Pediatric Living Donor Kidney Transplantation

Session Details / Access

19:15 - 21:00

Plenary: Innovation and Quality Improvement in Transplantation

Grainne M Walsh, United Kingdom
Patient Voices Video / Interviewer: Grainne Walsh, UK / Patient: Cecilia Adamou

Cassandra Smith-Fields, United States
Can we afford QI in transplant - administrator perspective

David K. Hooper, United States
Value of outcomes improvements through learning healthcare systems KIDNEY

George V. Mazariegos, United States
Value of outcomes improvements through learning healthcare systems LIVER

Session Details / Access

21:00 - 21:30

Networking: Zoom Virtual Hangouts

Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations.

Session Details / Access

Opening Ceremony and State-of-the-Art Session - 08:00 to 09:05

Oral Abstracts sessions - 09:15 to 10:25

Interactive Workshops - 10:30 to 11:40

SOTA Session - 11:45 to 12:15

Industry Symposium by Natera - 12:20 to 13:20

Networking Event

Oral Abstracts Sessions - 14:00 to 15:10

Plenary Session - 15:15 to 17:00

11:00 - 12:00	Networking: Zoom Virtual Hangouts Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations. Session Details / Access
Opening Ceremony and State-of-the-Art Session - 08:00 to 09:05
12:00 - 13:05	Opening Ceremony, Presidential Address and SOTA on Pandemic and Transplantation Mignon I McCulloch, South Africa Welcome to the Virtual IPTA 2022 Congress Carlos O. Esquivel, United States Welcome from the IPTA President Dmytro D. Ivanov, Ukraine The current situation of transplanted children in Ukraine Tomas Seeman, Czech Republic Welcome from Prague Organizing Chair and Concert by local transplant patients Mignon I McCulloch, South Africa Presidential Adress from IPTA Past President Emily A. Blumberg, United States Pandemic and Transplantation: Lessons learned from COVID-19 Session Details / Access
Oral Abstracts sessions - 09:15 to 10:25
13:15 - 14:25	Oral Abstracts Session: Liver Clinical - Part 1 Su young Hong, Korea Renal Replacement Therapy Is An Alarm Sign of Survival Outcome in Pediatric Liver Transplantation Eui Soo Han, Korea Long-term outcomes of left lateral segment grafts in low-weight pediatric recipients liver transplantation: comparing reduced versus full grafts Florian Brinkert, Germany Clinical outcome after combined liver and kidney transplantation in children in europe – a CERTAIN registry analysis Katherine Harmann, United States Immunizing pediatric liver transplant recipients against varicella virus using live-attenuated vaccination Proshad Efune, United States Intraoperative fluid administration during pediatric liver transplant surgery and postoperative outcomes: a retrospective multi-center analysis Christine Hwang, United States Pediatric Donation after Cardiac Death (DCD) Livers transplanted in adult recipients – appropriate utilization or missed opportunity for waitlisted children? Session Details / Access
13:15 - 14:25	Oral Abstracts Session: Infectious Disease and Malignancies Olivia M Martinez, United States Mutations in Latent Membrane Protein 1 of Epstein Barr Virus are Associated with Increased Risk of Post-transplant Lymphoproliferative Disorder Masaki Yamada, Japan Early detection of Epstein Barr virus and cytomegalovirus seronegative donors are the risk factors of chronic high Epstein-Barr viral load carriage after pediatric living-donor-dominated liver transplantation program. Joao Seda Neto, Brazil Unresectable hepatoblastoma and pre-transplant factors associated with event-free survival Jorge Arroyo Orvañanos, Mexico Cytomegalovirus Infection and Disease in Pediatric Liver Transplantation: Burden of Disease Under a Preemptive Therapy Approach Helena Genberg, Sweden Single-dose rituximab induction may prevent EBV viremia in paediatric kidney recipients long-term: an investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG) Olga Charnaya, United States Risk of Post-Transplant Malignancy in Pediatric Kidney Transplant Recipients is not Influenced by Induction Immunosuppression Session Details / Access
13:15 - 14:25	Oral Abstracts Session: Immunosuppression Roberto Tambucci, Belgium Is ABO incompatible living donor liver transplantation really a good alternative for pediatric recipients? Alisha Mavis, United States Do Surveillance Liver Biopsies Alter the Immunosuppression Regimen in Pediatric Liver Transplant Recipients? Thurid Ahlenstiel-Grunow, Germany Steering of immunosuppression by virus-specific T cells after pediatric kidney transplantation in the randomized controlled IVIST trial Paul Grimm, United States Sequential hematopoietic stem cell transplantation (HSCT) followed by kidney transplant- 3 children who received αβT-cell/CD19 B-cell depleted HSCT followed by kidney transplant from same parental donor are rejection free and immunosuppression free with donor specific tolerance > 1year post kidney transplant Mary M Chandran, United States Impact of once-daily extended-release tacrolimus intrapatient variability in stable adolescent and young adult renal transplant recipients – 3 year results Ashlene McKay, Canada LDL apheresis for FSGS recurrence in pediatric kidney transplant recipients: A case series Session Details / Access
Interactive Workshops - 10:30 to 11:40
14:30 - 15:40	Workshop: IPTA-SPLIT Session on Addressing the gap between pediatric organ demand and supply: New strategies to increase the graft pool Mureo Kasahara, Japan Use of non-conventional organs Monosegmental liver Living donation: A necessary technical evolution to care for the very small? Blayne Amir Sayed, Canada Living donation: Living donation for acute liver failure- is this possible and ethically acceptable? Gordon Thomas, Australia High risk organs and Livers from DCDs: When should these be considered in pediatrics? Session Supported by Session Details / Access
14:30 - 15:40	Workshop: IPTA-IPNA workshop on Equity, access and outcomes of pediatric kidney transplant recipients in 2022 Ruth McDonald, United States PTLD prediction based on Epstein-Barr viral loads Hui Kim Yap, Singapore Improving access to transplantation internationally Paul Grimm, United States Making the right decision in accepting deceased donor organ offers at 3am Session Supported by Session Details / Access
14:30 - 15:40	Workshop: IPTA-IRTA workshop on Optimizing Intestinal Transplant Options Taizo Hibi, Japan The future options to expand the donor pool (living donor, dcd, perfusion) Yaron Avitzur, Canada Intestinal rehabilitation and intestinal failure: When to transplant Jennifer Garcia, United States Intestinal Transplant Puzzle: Picking the right pieces Session Supported by Session Details / Access
SOTA Session - 11:45 to 12:15
15:45 - 16:15	State-of-the-Art Session: CRISPR and Transplantation Valeria R. Mas, United States CRISPR and Transplantation Session Details / Access
Industry Symposium by Natera - 12:20 to 13:20
16:20 - 17:20	Industry Symposium: Integrating Donor-Derived Cell-Free DNA in Your Transplant Monitoring Toolkit Hossein Tabriziani, United States Sara Jandeska, United States Natera Industry Symposium Session Details / Access
Networking Event
17:20 - 17:25	Live Virtual Stretching Break Break Supported by Session Details / Access
17:25 - 17:55	Networking: Prague Trivia & Toast Mignon I McCulloch, South Africa IPTA 2022 Virtual Toast Tomas Seeman, Czech Republic Prague Trivia Game Session Details / Access
Oral Abstracts Sessions - 14:00 to 15:10
18:00 - 19:10	Oral Abstracts Session: Kidney Clinical - Part 1 Felicia Kjaernet, Sweden Long-term outcome and complications in paediatric ABO-incompatible living donor kidney transplantation with rituximab induction: A multi-centre investigation from the Nordic Paediatric Renal Transplantation Study Group (NPRTSG) Dechu Puliyanda, United States Long term tolerability and clinical outcomes associated with Tocilizumab (TCZ) therapy in the treatment of refractory antibody mediated rejection (ABMR) in 25 pediatric renal transplant recipients Asha Moudgil, United States Prevalence of Mycophenolate Mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: a PNRC study Hyunwoong Chae, Canada Adrenal insufficiency in pediatric kidney transplant recipients Charlotte E Withers, United Kingdom National study on the risks of COVID-19 for paediatric renal transplant recipients Femke HM Vrieling-Prince, Netherlands Renal graft loss during adolescence: is there a relationship between pubertal stage and activity of the immune system? Session Details / Access
18:00 - 19:10	Oral Abstracts Session: Allied Health Saba Masood, United States A qualitative examination of posttraumatic stress symptoms in pediatric solid organ transplant patients: What is the traumatic stressor and how do the symptoms manifest? Elizabeth S Christofferson, United States Disparities and Barriers Associated with Pediatric Transplant Evaluation: A Comprehensive Analysis of the Impact on Time to Listing Catherine Patterson, Canada Allied health and nursing practices in pediatric solid organ transplantation: An international survey Robin Deliva, Canada Functional performance in pediatric heart transplant candidates and recipients: a retrospective review Nikol K. Grishin, Canada VEXT-A Virtual Exercise Training Program for Solid Organ Transplant Recipients Jo Wray, United Kingdom Quality of life of paediatric cardiothoracic transplant patients: parent-child agreement and association with family impact Session Details / Access
18:00 - 19:10	Oral Abstracts Session: Miscellaneous Esra Baskin, Turkey Long Term Effects of Eplerenone Treatment in Children with Chronic Allograft Dysfunction Gabor A. Dunay, Germany The role of tissue resident memory T cells in pediatric liver transplantation Huib de Jong, Netherlands Neutrophil gelatinase-associated lipocalin (NGAL) and Interleukine-18 (IL-18) in graft urine correlate with the rate of recovery of transplanted kidneys in children Arpit Amin, United States Kidney transplant in pediatric gut transplant recipients – Technical Challenges and Outcomes Raphael Schild, Germany Outcome after pediatric kidney transplantation from very small donors: a match-controlled CERTAIN Registry study. Christine Hwang, United States Delayed Graft Function In Pediatric Living Donor Kidney Transplantation Session Details / Access
Plenary Session - 15:15 to 17:00
19:15 - 21:00	Plenary: Innovation and Quality Improvement in Transplantation Grainne M Walsh, United Kingdom Patient Voices Video / Interviewer: Grainne Walsh, UK / Patient: Cecilia Adamou Cassandra Smith-Fields, United States Can we afford QI in transplant - administrator perspective David K. Hooper, United States Value of outcomes improvements through learning healthcare systems KIDNEY George V. Mazariegos, United States Value of outcomes improvements through learning healthcare systems LIVER Session Details / Access
21:00 - 21:30	Networking: Zoom Virtual Hangouts Zoom room(s) will be open for participants to informally meet each other whether it's for a simply hello or to dive into deeper conversations. Session Details / Access